Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Merimsky

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 27, 2022
The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitorsBarliz Waissengein, Bian Abu Ata, Ofer Merimsky, et al.
The Israel Medical Association Journal : IMAJ|December 31, 2020
Rising Incidence of Lung Cancer in Arab Females, Jewish Females, and Arab Males from 1990 to 2014 in IsraelJair Bar, Marina Perelman, Damien Urban, et al.
Cancer|November 21, 2023
Reply to "Metformin as a booster or obstacle of immunotherapy in patients with non-small cell lung cancer and diabetes mellitus"Yasmin Leshem, Yardenna Dolev, Nava Siegelmann-Danieli, et al.
Acta Oncologica (Stockholm, Sweden)|July 21, 2017
Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study<sup></sup>Hans Gelderblom, Ian R Judson, Charlotte Benson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 17, 2020
Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditisShira Peleg Hasson, Benjamin Salwen, Ayelet Sivan, et al.
Anticancer Research|November 27, 2008
Invasive breast cancer treated with taxol and epirubicin neo-adjuvant chemotherapy: the role in the outcome of the "crosstalk" between Erb receptors and p53David Sarid, Ilan G Ron, Lior Shoshan, et al.
Cancers|January 8, 2023
Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective AnalysisShira Peleg Hasson, Dov Hershkovitz, Lyri Adar, et al.
International Journal of Cardiology|December 8, 2023
The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumabYasmin Leshem, Tal Etan, Yardenna Dolev, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 5, 2021
Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied ManifestationShira Peleg Hasson, Joshua Arnold, Ilan Merdler, et al.
Lung|June 27, 2014
EGFR mutation testing practice in advanced non-small cell lung cancerJair Bar, Arnold Cyjon, Dov Flex, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 27, 2022
The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitorsBarliz Waissengein, Bian Abu Ata, Ofer Merimsky, et al.
The Israel Medical Association Journal : IMAJ|December 31, 2020
Rising Incidence of Lung Cancer in Arab Females, Jewish Females, and Arab Males from 1990 to 2014 in IsraelJair Bar, Marina Perelman, Damien Urban, et al.
Cancer|November 21, 2023
Reply to "Metformin as a booster or obstacle of immunotherapy in patients with non-small cell lung cancer and diabetes mellitus"Yasmin Leshem, Yardenna Dolev, Nava Siegelmann-Danieli, et al.
Acta Oncologica (Stockholm, Sweden)|July 21, 2017
Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study<sup></sup>Hans Gelderblom, Ian R Judson, Charlotte Benson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 17, 2020
Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditisShira Peleg Hasson, Benjamin Salwen, Ayelet Sivan, et al.
Anticancer Research|November 27, 2008
Invasive breast cancer treated with taxol and epirubicin neo-adjuvant chemotherapy: the role in the outcome of the "crosstalk" between Erb receptors and p53David Sarid, Ilan G Ron, Lior Shoshan, et al.
Cancers|January 8, 2023
Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective AnalysisShira Peleg Hasson, Dov Hershkovitz, Lyri Adar, et al.
International Journal of Cardiology|December 8, 2023
The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumabYasmin Leshem, Tal Etan, Yardenna Dolev, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 5, 2021
Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied ManifestationShira Peleg Hasson, Joshua Arnold, Ilan Merdler, et al.
Lung|June 27, 2014
EGFR mutation testing practice in advanced non-small cell lung cancerJair Bar, Arnold Cyjon, Dov Flex, et al.
Pageof 8